This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Industrial Technology Research Institute, National Health Research Institutes, Shin Kong Wu Ho Su Memorial Hospital. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2010
Title: Pei-Hsiu Liao: Innovator in Myasthenia Gravis Diagnosis
Introduction
Pei-Hsiu Liao is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of myasthenia gravis. His innovative work has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
Pei-Hsiu Liao holds a patent for a "Method of diagnosing myasthenia gravis and kits therefor." This invention relates to methods of diagnosing myasthenia gravis in a subject by determining an amount of at least one autoantibody that specifically binds to one or more autoantigens selected from heat-shock protein 60 (hsp60), heat-shock protein 90, alpha isoform (hsp90α), and heat-shock protein 90, beta isoform (hsp90β). The invention also provides diagnostic kits for identifying a subject having myasthenia gravis.
Career Highlights
Throughout his career, Pei-Hsiu Liao has worked with esteemed organizations such as the Industrial Technology Research Institute and the National Health Research Institutes. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical diagnostics.
Collaborations
Pei-Hsiu Liao has collaborated with notable colleagues, including Tzu-Ling Tseng and Ping-Fu Cheng. These collaborations have contributed to the advancement of research and development in the field of myasthenia gravis diagnosis.
Conclusion
Pei-Hsiu Liao's contributions to the diagnosis of myasthenia gravis through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in medical diagnostics and offers hope for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile